This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Celyntra Therapeutics Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jamie Kershner: Innovator in Genome Editing
Introduction
Jamie Kershner is an accomplished inventor based in Louisville, Colorado. He has made significant contributions to the field of genome editing, focusing on innovative methods and systems that enhance the precision of genetic modifications. His work is pivotal in advancing genetic engineering techniques that can be applied to various species, including humans.
Latest Patents
Kershner holds a patent titled "Constructs and uses thereof for efficient and specific genome editing." This patent encompasses novel nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems. The embodiments disclosed in the patent detail methods that include engineered non-naturally occurring nucleic acid-guided nucleases, which can be utilized with known guide nucleic acids. These systems are designed to edit targeted genomes effectively, employing techniques such as recursive genetic engineering and trackable genetic engineering methods.
Career Highlights
Kershner's career is marked by his dedication to advancing genetic engineering. His innovative approaches have positioned him as a key figure in the development of efficient genome editing technologies. His work not only contributes to scientific knowledge but also has practical implications for various applications in biotechnology and medicine.
Collaborations
Throughout his career, Kershner has collaborated with notable colleagues, including Rongming Liu and Liya Liang. These partnerships have fostered a collaborative environment that enhances the research and development of cutting-edge genetic engineering solutions.
Conclusion
In summary, Jamie Kershner is a pioneering inventor whose work in genome editing is shaping the future of genetic engineering. His patent and collaborative efforts reflect his commitment to innovation in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile